Attention‐deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: A nationwide population‐based cohort study

L Li, Z Chang, J Sun, M Garcia‐Argibay… - World …, 2022 - Wiley Online Library
Accumulating evidence suggests a higher risk for cardiovascular diseases among
individuals with mental disorders, but very little is known about the risk for overall and …

Attention‐deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases: A systematic review and meta‐analysis

L Li, H Yao, L Zhang, M Garcia‐Argibay… - JCPP …, 2023 - Wiley Online Library
Attention‐deficit/hyperactivity disorder (ADHD) often co‐occurs with other psychiatric and
physical diseases. However, available evidence on associations between ADHD and …

Association between history of attention-deficit/hyperactivity disorder diagnosis and cardiovascular disease in US adults.

G Xu, LG Snetselaar, L Strathearn, K Ryckman… - Health …, 2022 - psycnet.apa.org
Objective: To examine the association between attention-deficit/hyperactivity disorder
(ADHD) and cardiovascular disease (CVD) in a nationally representative population sample …

Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases

L Zhang, L Li, P Andell, M Garcia-Argibay… - JAMA …, 2024 - jamanetwork.com
Importance Use of attention-deficit/hyperactivity disorder (ADHD) medications has increased
substantially over the past decades. However, the potential risk of cardiovascular disease …

Childhood attention-deficit hyperactivity disorder problems and mid-life cardiovascular risk: prospective population cohort study

AK Thapar, L Riglin, R Blakey, S Collishaw… - The British Journal of …, 2023 - cambridge.org
BackgroundIt is well-known that childhood attention-deficit hyperactivity disorder (ADHD) is
associated with later adverse mental health and social outcomes. Patient-based studies …

Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis

L Zhang, H Yao, L Li, E Du Rietz, P Andell… - JAMA Network …, 2022 - jamanetwork.com
Importance Use of attention-deficit/hyperactivity disorder (ADHD) medications has increased
substantially over the past decades, but there are concerns regarding their cardiovascular …

The role of ADHD genetic risk in mid-to-late life somatic health conditions

M Garcia-Argibay, E du Rietz, Y Lu, J Martin… - Translational …, 2022 - nature.com
Growing evidence suggests that ADHD, an early onset neurodevelopmental disorder, is
associated with poor somatic health in adulthood. However, the mechanisms underlying …

ADHD medications and risk of serious cardiovascular events in young and middle-aged adults

LA Habel, WO Cooper, CM Sox, KA Chan, BH Fireman… - Jama, 2011 - jamanetwork.com
Context More than 1.5 million US adults use stimulants and other medications labeled for
treatment of attention-deficit/hyperactivity disorder (ADHD). These agents can increase heart …

Association of ADHD medications with the risk of cardiovascular diseases: a meta-analysis

H Liu, W Feng, D Zhang - European child & adolescent psychiatry, 2019 - Springer
This meta-analysis was conducted to evaluate the association between Attention deficit
hyperactivity disorder (ADHD) medications and risk of sudden death/arrhythmia, stroke …

Psychiatric disorders and subsequent risk of cardiovascular disease: a longitudinal matched cohort study across three countries

Q Shen, DH Mikkelsen, LB Luitva, H Song… - …, 2023 - thelancet.com
Background Several psychiatric disorders have been associated with increased risk of
cardiovascular disease (CVD), however, the role of familial factors and the main disease …